165393-06-6

165393-06-6 structure

Name: Urolithin C
Chemical Name: Urolithin C
CAS Number: 165393-06-6
Molecular Formula: C₁₃H₈O₅
Molecular Weight: 244.200
Catalog: Signaling Pathways Apoptosis Apoptosis
Create Date: 2018-03-10 08:00:00
Modify Date: 2024-01-02 16:51:33
Urolithin C, a gut-microbial metabolite of Ellagic acid, is a glucose-dependent activator of insulin secretion. Urolithin C is a L-type Ca2+ channel opener and enhances Ca2+ influx. Urolithin C induces cell apoptosis through a mitochondria-mediated pathway and also stimulates reactive oxygen species (ROS) formation[1][2].

Name	Urolithin C
Synonyms	Urolithin C Uro C 3,8,9-thihydroxy-6H-benzo[c]chromen-6-one 6H-Dibenzo[b,d]pyran-6-one, 3,8,9-trihydroxy- 3,8,9-Thihydroxybenzo[c]chromen-6-one 3,8,9-Trihydroxy-6H-benzo[c]chromen-6-one 3,8,9-trihydroxy-6H-dibenzo[b,d]pyran-6-one

Description	Urolithin C, a gut-microbial metabolite of Ellagic acid, is a glucose-dependent activator of insulin secretion. Urolithin C is a L-type Ca2+ channel opener and enhances Ca2+ influx. Urolithin C induces cell apoptosis through a mitochondria-mediated pathway and also stimulates reactive oxygen species (ROS) formation[1][2].
Related Catalog	Signaling Pathways >> Membrane Transporter/Ion Channel >> Calcium Channel Signaling Pathways >> Apoptosis >> Apoptosis Research Areas >> Metabolic Disease
Target	Insulin secretion[1] L-type Ca2+ channel[1] Reactive oxygen species (ROS)[2] Apoptosis[2]
In Vitro	Urolithin C (20-100 μM; 1 hour; INS-1 cells) treatment enhances glucose-induced extracellular signal-regulated kinases 1/2 (ERK1/2) activation in INS-1 β-cells[1]. Urolithin C significantly inhibits the proliferation of PC12 cells. Urolithin C treatment actively increases the lactate dehydrogenase (LDH) release and lipid peroxidation malondialdehyde (MDA), stimulates reactive oxygen species (ROS) formation and mitochondrial membrane depolarization, and caused calcium dyshomeostasis[2]. Urolithin C treatment induces apoptosis and S phase cell cycle arrest[2]. Western Blot Analysis[1] Cell Line: INS-1 cells Concentration: 20 μM, 100 μM Incubation Time: 1 hour Result: Enhanced glucose-induced extracellular signal-regulated kinases 1/2 (ERK1/2) activation.
In Vivo	The pharmacokinetics of Urolithin C (10 mg/kg; intraperitoneal administration) in male Wistar rat (140-160 g) are studied. The half-life of the terminal part is 11.3 h and the total clearance (CL/F) is 3.41 L/h/kg. The initial volume of distribution (V1/F) and the steady-state volume of distribution (Vss/F) are 0.831 L/kg and 55.6 L/kg, respectively[3].
References	[1]. Slimane Toubal, et al. Urolithin C Increases Glucose-Induced ERK Activation Which Contributes to Insulin Secretion. Fundam Clin Pharmacol. 2020 Feb 21. [2]. Peipei Yin, et al. Urolithin C, a gut metabolite of ellagic acid, induces apoptosis in PC12 cells through a mitochondria-mediated pathway. RSC Advances. Issue 28, 2017. [3]. Morgane Bayle, et al. Development and Validation of a Liquid Chromatography-Electrospray Ionization-Tandem Mass Spectrometry Method for the Determination of Urolithin C in Rat Plasma and Its Application to a Pharmacokinetic Study. J Pharm Biomed Anal. 2016 Nov 30;131:33-39.

Density	1.6±0.1 g/cm3
Boiling Point	605.4±55.0 °C at 760 mmHg
Molecular Formula	C₁₃H₈O₅
Molecular Weight	244.200
Flash Point	243.6±25.0 °C
Exact Mass	244.037170
PSA	90.90000
LogP	1.88
Vapour Pressure	0.0±1.8 mmHg at 25°C
Index of Refraction	1.758

165393-06-6	713519-19-8
126438-35-5	1139-83-9
1143-70-0	131086-98-1
531512-26-2	35233-17-1
1143-62-0	111514-63-7